Let's hope they doubled up today. I bought this for a trade anticipating "not-as-bad-as-SSYS" numbers, but it did a lot better than that. I think I'll keep it.
Analogies are meaningless. In terms of subscribers, NFLX has tremendous growth. When GILD announced the dividend and share buyback, they transitioned from a growth play to a growth/value play. Which, given today's market, was a good thing. (XBI -5%, GILD -2.75%)
With all due respect, while I agree with the tactic of cutting losses quickly, I think you misunderstand this stock. It can be moved by oil prices, interest rates, sector performance ,etc ... but it doesn't belong in taxable accounts, where it can be a value trap. In tax-advantaged accounts, it provides an income stream of 11% p.a. ...actually 11.4% if, instead of selling at this morning's lows, you had added shares. A good rule is that when you are buying stocks which are new to you, buy them a little at a time, until you can understand the dynamics in play.
The poster is obviously disappointed with the measly 11% yield. (Closer to 11.5% on the shares I added this morning.) CLMT, needless to say, has absolutely nothing to do with PAA.
No doubt a delayed report of amalgamated trades made earlier in the day. Also a bid for 54,000 shares @ 13.60 showing. A lot of major shorts got caught her, I think No reason not to hold this for a while.
As I've said before, this is not about the refining sector but about a stream of earnings for tax-advantaged accounts. Incidentally, they raised the possibility of increasing the dividend in the future in their report.
Stan, you're pathetic. Of all the pharma stocks you could pick to buy puts on, you choose one with huge cashflow and strong support.. Note that the IBB is down 3.8% at this point, and the XBI s down 5%. GILD is down 2.6% and should close no lower than 115.50. Meanwhile, BII -5.15%, ICPT -7.6%, and many of the smaller biotech are down close to 10%. This is a dy when one should be adding to positions in any pharma stock one believes in, not wasting your time jawing about NFLX.
As I expected, their investment in consumer advertising is holding back profitability but helping to drive sales. If you read the consumer reviews, the number of peple who describe Linzess as "a miracle" is impressive.
I agree that a short who is trying to squeeze the last dollar out of this is taking a greater risk than someone going long here. This could be driven either way on anything other than abysmal earnings.
"The trend is your friend," some say. However, noting that the volume here has been fairly brisk for the last four sessions while the percentage of trades short is small, I have added a bit. If it disappoints, there should be a short covering rally. The SSYS situation is a perfect setup for a short trap.
FWIW, one of my rules is that whenever you own a stock which surprises to the upside or the downside, sell half right away. And when something happens which calls into question your basic premise for owning a stock (e.g. IMMU last week for me), sell it all.
Well, although I don't do much trading anymore, I will confess that I'm trading this to prove a theory that this is one of those stocks where the options lead the way.
Okay, i'm long this turkey, counting on the blithe optimism rampant here, but clue me in: What wonderful thing is happening on Aug. 13?
If it drops .25, I will add some. Incidentally, I thought this was a breakout/acquisition/short trap story. And you're playing it for a lousy quarter? Note that I a violating one of Guy Adami's very good rules, "Never trade out of boredom."
I think that was a mistake. My guess is that 8.60 - 8.70 is the short term bottom for this baby. Any lower than that and it gets hard to peddle those Aug10 calls. I look for this to move up in advance of expiration. If I were going to short this, I would wait until the week of the 17'th.
You're right - I stand corrected. You seem to follow this stock more closely than I do ... and I own it.